ME News reports that on July 2 (UTC+8), FBI Director Kash Patel was revealed to have disclosed his purchase of MSTR stock more than six months after the transaction, violating the STOCK Act’s 45-day disclosure requirement. Patel bought MSTR shares valued between $100,000 and $250,000 on November 21, 2025, but did not file the disclosure until May 26, 2026. He attributed the delay to “communication errors” and “unintentional oversight.” Deputy Assistant Attorney General William Taylor stated that the transaction did not constitute a conflict of interest, and the DOJ has not imposed any penalties on Patel. A first-time violation of the STOCK Act typically results in a $200 fine. (Source: Foresight News)
FBI Director Allegedly Violated the STOCK Act by Delaying MSTR Stock Disclosure
KuCoinFlashShare
Summary
FBI Director Kash Patel reportedly violated the STOCK Act by failing to disclose a six-figure purchase of MSTR stock within the required 45-day window. Patel bought $100,000–$250,000 worth of MSTR shares on November 21, 2025, but filed the disclosure on May 26, 2026. He attributed the delay to a “communication error” and “unintentional omission.” DOJ’s William Taylor stated the transaction does not present a conflict of interest and no penalties have been imposed. First-time violations typically result in a $200 fine. The incident has reignited scrutiny over CFTC regulations and their impact on risk-on assets.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.